U bent succesvol uitgelogd.

Hallo !
Logout
Contact

Samen sneller naar de finish

Complexe wonden

Voorkom complicaties en versnel wondgenezing, gebruik Prontosan® en Askina® Calgitrol® als duo-oplossing. Een complexe wond geneest gemiddeld 4 weken sneller en binnen 2 weken is een wondinfectie onder controle. [1,3,4] Prontosan® voorkomt en behandelt biofilm. Askina® Calgitrol® pasta pakt infectie aan.

Klinisch bewijs en artikelen

  • 0%

    van de complexe wonden is naar schatting geïnfecteerd. [6-7]

  • 0%

    van de complexe wonden bevat biofilm met een rol bij wondinfectie. [8-11]

Referenties

[1] Eberlein T., Expert assessment on the benefits of systematic application of Prontosan® solution in wound treatment with particular focus on cost-efficiency when compared to current standard treatment (saline/Ringer), Internal data, 2006.

[2] Bellingeri, A., Effect Of A Wound Cleansing Solution On Wound Bed Preparation And Inflammation In Chronic Wounds: A Single-Blind RCT”. Journal of Wound Care, 2016, 160-168. Web.

[3] International Wound Infection Institute (IWII) Wound infection in clinical practice. Wounds International 2016

[4] Sibbald RG, Goodman L, Krasner DL, et al. Special considerations in Wound Bed Preparation 2011: An Update. Adv Skin Wound Care 2011; 415-36.

[5] Experiences in using polyhexanide containing wound products in the management of chronic wounds – results of a methodical and retrospective analysis of 953 cases. Moeller A, Nolte A, Kaehn K. Wundmanagement 2008; 3:112-117

[6] Reitan RL, McBroom RM, Gilder RE. The Risk of Infection and Indication of Systemic Antibiotics in Chronic Wounds. Wounds. 2020 Jul;32(7):186-194. PMID: 33166266.

[7] Schollemann F, Kunczik J, Dohmeier H, Pereira CB, Follmann A, Czaplik M. Infection Probability Index: Implementation of an Automated Chronic Wound Infection Marker. J Clin Med. 2021 Dec 29;11(1):169. doi: 10.3390/jcm11010169. PMID: 35011910; PMCID: PMC8745914

[8] Malone M, Bjarnsholt T, McBain AJ, James GA, Stoodley P, Leaper D, Tachi M, Schultz G, Swanson T, Wolcott RD. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care. 2017 Jan 2;26(1):20-25. doi: 10.12968/jowc.2017.26.1.20. PMID: 28103163.

[9] Honorato-Sampaio K, Guedes AC, Lima VL, Borges EL. Bacterial biofilm in chronic venous ulcer. Braz J Infect Dis. 2014 May-Jun;18(3):350-1. doi: 10.1016/j.bjid.2014.01.003. Epub 2014 Mar 21. PMID: 24662137

[10] Hurlow J, Bowler PG. Acute and chronic wound infections: microbiological, immunological, clinical and therapeutic distinctions. J Wound Care. 2022 May 2;31(5):436-445. doi: 10.12968/jowc.2022.31.5.436. PMID: 35579319.

[11] Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999 May 21;284(5418):1318-22. doi: 10.1126/science.284.5418.1318. PMID: 10334980.